Triagem para doença de Fabry – um estudo transversal com uma nova abordagem clínica
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Introduction: Fabry disease is an inherited disease linked to the X chromosome. It is an
innate error in the metabolism of glycosphingolipids. Due to the absence or deficiency of α
galactosidase A, accumulation of globotriasylceramid occurs in the tissues, leading to
considerable morbidity and mortality. Most of the studies only evaluated men on
hemodialysis.
Objectives: 1- To evaluate the prevalence of Fabry disease in dialysis centers in Brazil in
males and females, initially used a questionnaire and then an computational algorithm that
selects the suspected cases for blood collection. 2- To evaluate the presence and importance of
the main signs and symptoms in these kidney disease patients.
Methods: This study is a secondary data analysis from a multicentric project: Clinical and
Epidemiological Analysis of Fabry Disease in Brazilian Dialysis Center: “Brazil Fabry
Kidney Project”. The study included 854 dialysis centers throughout Brazil. Patients and
family who signed the Informed Consent Term were evaluated. After the questionnaire was
applied to the patient, this data was entered into a computerized system. This algorithm
separates into discard, those who probably do not have Fabry's disease, into suspects, those
who were referred for blood collection and analysis, and those who the system had doubts
about and needs the intervention of program creators to decide whether to collect. When
detected suspect patients, they had blood collected on filter paper for enzymatic dosing and
genetic testing. A descriptive analysis of the data was performed, the likelihood ratio between
the symptoms of Fabry disease patients and with kidney disease vs Fabry disease without
kidney disease. The likelihood ratio was also performed in the groups of analysis vs discard,
collection vs discard and positive vs negatives.
Results: 36442 individuals with kidney disease were screened and 71 patients with Fabry
disease were found. Searched 1214 individuals among the relatives of the positive patients
and found another 115 individuals with Fabry. There were 37656 patients, 28284 of which
were discarded and 9301 referred for analysis. Of them, 186 were positive in the total sample.
The Fabry disease prevalence in the population with kidney disease was 0.19% before the
questionnaire and the algorithm were used and 0.87% after. Among the relatives was 9.47%.
In the total population of the study was 0.49% and in those screened by the algorithm, 2.24%.
There was a higher prevalence of women (65.1%), although more men were screened
(59.3%). Two groups were separated: Fabry disease with kidney disease (71) and Fabry
disease without kidney disease (115). Regarding signs, symptoms and comorbidities,
rheumatologic diseases were more frequent (71.8%) followed by heart disease (60.6%),
decrease or absence of sweating (42.3%), arterial hypertension (35.2%), depression (28.2%),
intolerance to heat and cold (28.2%), pain crises that spread through the body (26.8%),
neurological diseases (25.4%), burning sensation in the hands and feet (23.9%), numbness
sensation in the hands and feet (22.5%), and recurrent fever (16.9%) in those with kidney
disease.
Conclusion: We found prevalence close to that described in the literature, when the
questionnaire and the algorithm were not used. Using the questionnaire and the algorithm,
prevalence rises in all screening population including family members. Considering only the
population with kidney disease the prevalence was 0.19% before the questionnaire and
algorithm were used and 0.87%, after the questionnaire and algorithm. In the relatives of
Fabry disease patients, the prevalence was 9.47%. In total study population was 0.49% before
using the questionnaire and algorithm and 2.24% after that. We also found a higher
prevalence of the Fabry disease in females. We noticed that the group with kidney disease has
more signs and symptoms. We believe that the use of the algorithm increases the sensitivity of
the questionnaire, allowing the diagnosis of a greater number of cases, restricting the
laboratory analysis to cases of greater risk.
Description
Keywords
Doença de Fabry , Doença renal , Brasil , Triagem , Fabry diseases , Kidney diseases , Brazil , Screening
Citation
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
